Solutions from Process Development to Commercial Manufacturing for Monoclonal Antibodies
Scalable and Cost-Efficient Single-Use Toolbox for Your mAb Process Platform
By combining our expertise in cell line development and cultivation, media optimization, virus clearance, filtration and polishing of mAbs we provide a complete Toolbox of Solutions which can be adapted in-house or at contract manufacturing organizations.
An Interview with Synthon
In an exclusive interview with Miriam Monge, Head of Segment Marketing mAb at Sartorius, Nienke Vriezen, Synthon’s Director of USP Development and Manufacturing talks about how Sartorius helped Synthon to rapidly implement a flexible single-use facility for the manufacture of monoclonal antibodies.
Founded in 1991, Synthon now employs 1,700 people at nine sites worldwide. The company develops biopharmaceuticals with a focus is on next-generation cancer drugs.